NCT02212210

Brief Summary

The purpose of this study is to look to see if adding steroids to an epidural reduces the chances of having a fever in labor, and protects the baby from exposure to inflammation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
135

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Feb 2012

Longer than P75 for early_phase_1

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 8, 2014

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

August 29, 2017

Status Verified

August 1, 2014

Enrollment Period

2.2 years

First QC Date

August 4, 2014

Last Update Submit

August 28, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of maternal fever

    Oral maternal temperature will be collected hourly starting at epidural placement. Temperature will be recorded until delivery.

    delivery

Secondary Outcomes (1)

  • Rate of funisitis

    delivery

Other Outcomes (1)

  • IL-6 level

    delivery

Study Arms (2)

Methylprednisolone

ACTIVE COMPARATOR

1cc of 80mg methylprednisolone to be diluted with 1cc preservative free normal saline

Drug: Methylprednisolone

Normal saline

PLACEBO COMPARATOR

2cc preservative free normal saline

Drug: Normal saline

Interventions

Also known as: DEPO-MEDROL
Methylprednisolone
Also known as: Saline placebo
Normal saline

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Nulliparity
  • Age\>=18
  • Patient requests epidural analgesia
  • GA \>= 37 weeks

You may not qualify if:

  • No prenatal care
  • Temperature \>99.4 at decision for epidural placement
  • Cervical dilation \>4cm
  • Diabetes (pre-gestational or gestational)
  • Autoimmune condition
  • Pre-eclampsia
  • Maternal heart disease
  • Current steroid use
  • Active infection (bacterial or viral)
  • Wet Tap (CSF on placement of epidural)
  • Pre-gestational diabetes
  • Known systemic infection (bacterial, viral, fungal or tubercular)
  • Known allergy to steroids
  • Heart failure
  • Hypertensive crisis
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

FeverLabor Pain

Interventions

MethylprednisoloneMethylprednisolone AcetateSaline Solution

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsPainNeurologic Manifestations

Intervention Hierarchy (Ancestors)

PrednisolonePregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Christopher G Goodier, MD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor

Study Record Dates

First Submitted

August 4, 2014

First Posted

August 8, 2014

Study Start

February 1, 2012

Primary Completion

April 1, 2014

Study Completion

October 1, 2015

Last Updated

August 29, 2017

Record last verified: 2014-08

Locations